NUVB

Nuvation Bio Inc

6.26

+0.46+7.93%

Pre Market: 6.37 +0.11 +1.76%05:52 07/21 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE5.87/5.80

TODAY RANGE5.87-6.52

VOL216

MARKET CAP2.18B

52 WEEK RANGE2.180-9.75

AVG VOL (3M)6.24M

% TURNOVER3.43%

TURNOVER0

P/E (TTM)-14.6228

% RANGE10.58%

EPS(TTM)-0.4281

P/E(FORWARD)-18.6866

P/B6.79

BVPS0.9223

DIVIDEND--

P/S34.49

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP1.77B

SHARES OUTSTANDING348.20M

NEXT EARNINGS08/05-08/10

FREE FLOAT283.35M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

NASDAQ·18h ago
Nuvation Updates Positive Safusidenib Data From Phase 2 Trial; Expands IDH1 Glioma Trials
TipRanks·19h ago
RBC looks for Nuvation shares to appreciate as safusidenib data builds
Dow Jones·19h ago
Nuvation Bio Shares Rise After Expanding Clinical Development Program for Cancer Drug
TipRanks·22h ago
Nuvation Bio announces data from the Phase 2 J201 study
PR Newswire·22h ago
Nuvation Bio Announces Positive Updated Phase 2 Data and Expansion of Safusidenib Clinical Program with Two New Studies to Explore Broad Spectrum of IDH1-Mutant Glioma
TipRanks·3d ago
Nuvation Bio Moves Safusidenib Into Phase 3, Raising Stakes in Targeted Brain Cancer
TipRanks·07/13 05:30
Analysts’ Top Healthcare Picks: Argenx Se (ARGX), Nuvation Bio (NUVB)
TipRanks·07/09 21:29
3 Under-$10 Stocks with Strong Upside to Watch This Week, According to Analysts
Dow Jones·07/07 16:28
Nuvation Bio Price Target Cut to $19.00/Share From $20.00 by RBC Capital
Dow Jones·07/07 16:28
Nuvation Bio Is Maintained at Outperform by RBC Capital
Dow Jones·07/07 12:36
Nuvation Bio Is Maintained at Buy by Truist Securities
Dow Jones·07/07 12:36
Nuvation Bio Price Target Raised to $13.00/Share From $12.00 by Truist Securities
TipRanks·07/06 21:50
Nuvation Bio Expands Convertible Notes Offering and Financing
Seeking Alpha·07/06 21:30
Nuvation Bio ups convertible notes offering to $287.5M after greenshoe exercise
PR Newswire·07/06 21:09
Nuvation Bio Inc. Announces Full Exercise of Greenshoe Option in $287.5 Million Convertible Senior Notes Offering

Same Industry

Name/Symbol

Change%

Price

NUVB

Regeneron Pharmaceuticals

REGN

-0.67%

672.15

GRDX

BIONTECH

BNTX

-0.09%

91.48

United Therapeutics Corp.

UTHR

+1.25%

535.67

Siga Technologie

SIGA

-3.37%

3.440

Vertex Pharmaceuticals Inc

VRTX

-0.08%

485.65

MRNA

CRL

MEDP

TLPH

ICLR

CBPO

Iqvia Hldgs Inc

IQV

-2.01%

206.26

MOLN

Arcturus Therape

ARCT

-2.10%

6.05

PRAH

GILD

Incyte Corp

INCY

+0.51%

117.25

Aptevo Therapeutics Inc

APVO

+5.33%

4.740

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.